Mitokinin is Drug Discovery in United States that focus on neo-substrates intended business. Founded in 2017. They cover business area such as developer, kinase-target neo-substrate, neurodegenerative and mitochondrial disease, alternative phospho-donor, physician.
2017
( 7 years old in 2024 )
Neo-substrates Intended
-
45 Broadway
Suite 1440
New York, NY 10006
United States
Private
developerkinase-target neo-substrateneurodegenerative and mitochondrial diseasealternative phospho-donorphysician
* We use standard office opening hours in near Mitokinin's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Mitokinin is Drug Discovery business from United States that founded in 2017 (7 years old in 2024), Mitokinin business is focusing on Neo-substrates Intended.
Mitokinin headquarter office and corporate office address is located in 45 Broadway Suite 1440 New York, NY 10006 United States.
Mitokinin was founded in United States.
In 2024, Mitokinin is currently focus on neo-substrates intended sector.
Above is snippet of Google Trends for "neo-substrates intended" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Mitokinin, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
